Dendritic cell prostate cancer vaccine is enhanced by inhibiting the SH2-domaincontaining phosphatase, SHP-1

被引：0
|
作者：
Levitt, J. M.
Ramachandran, I.
机构：
[1] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[2] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA
来源：
BJU INTERNATIONAL | 2007年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Role of the SH2 domain-containing Phosphatase-1, SHP-1 in Dendritic Cell Activation
    Ramachandran, Indu Rekha
    Levitt, Jonathan Michael
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [2] Protein tyrosine phosphatase SHP-1 regulates prostate cancer cell migration
    Cariaga-Martinez, A. E.
    Rodriguez-Ubreva, J.
    Suarez-Arias, S.
    Jesus Orea, M.
    Ropero, S.
    Lopez-Ruiz, P.
    Colas, B.
    FEBS JOURNAL, 2013, 280 : 395 - 395
  • [3] SH2 domain directed effectors of SHP-1 phosphatase activity
    Hampel, K.
    Kaufhold, I.
    Zacharias, M.
    Boehmer, F. D.
    Imhof, D.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 173 - 173
  • [4] The protein tyrosine phosphatase, SHP-1, is an intrinsic central regulator of dendritic cell function
    Levitt, Jonathan
    Ramachandran, Indu
    Spencer, David
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [5] The Expression of Tyrosin-Phosphatase SHP-1 Is a Novel Prognostic Marker in Prostate Cancer
    Lopez, J. I.
    Ferruelo, A.
    Colas, B.
    Lopez-Ruiz, P.
    Angulo, J. C.
    MODERN PATHOLOGY, 2009, 22 : 179A - 179A
  • [6] The Expression of Tyrosin-Phosphatase SHP-1 Is a Novel Prognostic Marker in Prostate Cancer
    Lopez, J. I.
    Ferruelo, A.
    Colas, B.
    Lopez-Ruiz, P.
    Angulo, J. C.
    LABORATORY INVESTIGATION, 2009, 89 : 179A - 179A
  • [7] Modulation of SHP-1 Phosphatase Activity by Monovalent and Bivalent SH2 Phosphopeptide Ligands
    Teichmann, Kathleen
    Kuehl, Toni
    Koennig, Ina
    Wieligmann, Karin
    Zacharias, Martin
    Imhof, Diana
    BIOPOLYMERS, 2010, 93 (01) : 102 - 112
  • [8] Tyrosin-phosphatase SHP-1 present in prostate cancer can be a novel marker of prognosis
    Angulo, J.
    Ferruelo, A.
    Lopez, J. I.
    Rodriguez-Barbero, J.
    Santana, A.
    Fernandez-Segoviano, P.
    Lujan, M.
    Garcia-Mediero, J.
    Pascual-Mateo, C.
    Lopez-Ruiz, P.
    Colas, B.
    Berenguer, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 149 - 149
  • [9] SH2 domain containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation
    Nakayama, T
    FASEB JOURNAL, 2003, 17 (07): : C15 - C15
  • [10] Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer
    Tassidis, Helena
    Brokken, Leon
    Ulmert, David
    Ehrnstrom, Roy
    Jirstrom, Karin
    Bjartell, Anders
    Harkonen, Pirkko
    Wingren, Anette Gjorloff
    CANCER RESEARCH, 2009, 69
12345